Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/c mice

Journal of Proteomics

Volumn 74, Issue 10, 2011, Pages 2025-2033

  Turiák, Lilla ^a   Misják, Petra ^b   Szabó, Tamás G ^b   Aradi, Borbála ^b   Pálóczi, Krisztina ^b   Ozohanics, Oliver ^a   Drahos, László ^a   Kittel, Ágnes ^c   Falus, András ^b   Buzás, Edit I ^b   Vékey, Károly ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Apoptotic body; Mass spectrometry; Microparticle; Microvesicle; Proteomics; Thymus

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CENTRIFUGATION; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEUKOCYTE ROLLING; MASS SPECTROMETRY; MEMBRANE VESICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; APOPTOSIS; EXOSOMES; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; PROTEOMICS; THYMOCYTES;

MUS;

EID: 80052035289     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.05.023     Document Type: Article

References (36)

1. Chao D.T., Korsmeyer S.J. BCL-X-L-regulated apoptosis in T cell development. Int Immunol 1997, 9:1375-1384.
2. Kyewski B., Klein L. A central role for central tolerance. Annu Rev Immunol 2006, 24:571-606.
3. Koble C., Kyewski B. The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J Exp Med 2009, 206:1505-1513.
4. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009, 9:581-593.
5. György B., Szabó G.T., Pásztói M., Pál Z., Misják P., Aradi B., László V., Pállinger É., Pap E., Kittel Á., Nagy G., Falus A., Buzás EI Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci, doi:10.1007/s00018-011-0689-3.
6. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
7. Pap E., Pallinger E., Pasztoi M., Falus A. Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 2009, 58:1-8.
8. Simpson R.J., Lim J.W.E., Moritz R.L., Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics 2009, 6:267-283.
9. Mathivanan S., Simpson R.J. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 2009, 9:4997-5000.
10. Ramacciotti E., Hawley A.E., Wrobleski S.K., Myers D.D., Strahler J.R., Andrews P.C., et al. Proteomics of microparticles after deep venous thrombosis. Thromb Res 2010, 125:E269-E274.
11. Mayr M., Grainger D., Mayr U., Leroyer A.S., Leseche G., Sidibe A., et al. Proteomics, metabolomics, and immunomics on microparticles derived from human atherosclerotic plaques. Circ Cardiovasc Genet 2009, 2:379-388.
12. Dean W.L., Lee M.J., Cummins T.D., Schultz D.J., Powell D.W. Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost 2009, 102:711-718.
13. Prokopi M., Pula G., Mayr U., Devue C., Gallagher J., Xiao Q., et al. Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood 2009, 114:723-732.
14. Smalley D.M., Ley K. Plasma-derived microparticles for biomarker discovery. Clin Lab 2008, 54:67-79.
15. György B., Módos K., Pállinger E., Pálóczi K., Pásztói M., Misják P., Deli M.A., Sipos A., Szalai A., Voszka I., Polgár A., Tóth K., Csete M., Nagy G., Gay S., Falus A., Kittel A., Buzás E.I. Detection and isolation of cell-derived microparticles are compromised by protein complexes due to shared biophysical parameters. Blood 2011, 117:e39-e48.
16. Chaiyarit S., Thongboonkerd V. Comparative analyses of cell disruption methods for mitochondrial isolation in high-throughput proteomics study. Anal Biochem 2009, 394:249-258.
17. Turiák, L, Ozohanics, O., Marino, F., Drahos, L. and Vékey, K., Digestion protcol for small protein amounts for nano-HPLC/MS(MS) analysis. J Proteomics, doi:10.1016/j.jprot.2011.01.007.
18. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
19. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
20. Silva J.C., Gorenstein M.V., Li G.Z., Vissers J.P.C., Geromanos S.J. Absolute quantification of proteins by LCMSE - a virtue of parallel MS acquisition. Mol Cell Proteomics 2006, 5:144-156.
21. Raijmakers R., Berkers C.R., de Jong A., Ovaa H., Heck A.J.R., Mohammed S. Automated online sequential isotope labeling for protein quantitation applied to proteasome tissue-specific diversity. Mol Cell Proteomics 2008, 7:1755-1762.
22. Hegmans J., Bard M.P.L., Hemmes A., Luider T.M., Kleijmeer M.J., Prins J.B., et al. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol 2004, 164:1807-1815.
23. Wubbolts R., Leckie R.S., Veenhuizen P.T.M., Schwarzmann G., Mobius W., Hoernschemeyer J., et al. Proteomic and biochemical analyses of human B cell-derived exosomes - potential implications for their function and multivesicular body formation. J Biol Chem 2003, 278:10963-10972.
24. Conde-Vancells J., Rodriguez-Suarez E., Embade N., Gil D., Matthiesen R., Valle M., et al. Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. J Proteome Res 2008, 7:5157-5166.
25. Goeb V., Thomas-L'Otellier M., Daveau R., Charlionet R., Fardellone P., Le Loet X., et al. Candidate autoantigens identified by mass spectrometry in early rheumatoid arthritis are chaperones and citrullinated glycolytic enzymes. Arthritis Res Ther 2009, 11:R38.
26. Lundberg K., Kinloch A., Fisher B.A., Wegner N., Wait R., Charles P., et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008, 58:3009-3019.
27. Lee J.H., Cho S.B., Bang D., Oh S.H., Ahn K.J., Kim J., et al. Human anti-alpha-enolase antibody in sera from patients with Behcet's disease and rheumatologic disorders. Clin Exp Rheumatol 2009, 27:S63-S66.
28. Routsias J.G., Tzioufas A.G. The role of chaperone proteins in autoimmunity. Neuroendocrine and Immune Crosstalk 2006, 1088:52-64.
29. Businaro R., Profumo E., Tagliani A., Buttari B., Leone S., D'Amati G., et al. Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis 2009, 207:74-83.
30. Koutouzov S., Jeronimo A.L., Campos H., Amoura Z. Nucleosomes in the pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am 2004, 30:529-558.
31. Chen H.Z., Tsai S.Y., Leone G. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer 2009, 9:785-797.
32. Hernandez J.D., Nguyen J.T., He J.L., Wang W., Ardman B., Green J.M., et al. Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death. J Immunol 2006, 177:5328-5336.
33. Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G. Apoptosis of T-cells mediated by galectin-1. Nature 1995, 378:736-739.
34. Krebs J., Wilson A., Kisielow P. Calmodulin-dependent protein kinase IV during T-cell development. Biochem Biophys Res Commun 1997, 241:383-389.
35. Crespin M., Vidal C., Picard F., Lacombe C., Fontenay M. Activation of PAK1/2 during the shedding of platelet microvesicles. Blood Coagul Fibrinolysis 2009, 20:63-70.
36. Beckers C.M.L., van Hinsbergh V.W.M., Amerongen G.P.V. Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb Haemost 2010, 103:40-55.